Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
Peking University · Peking University People's Hospital · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
565
total citations
- FWCI
- 27.40
- Percentile
- 100%
- References
- 28
Citations per year
Authors
32- JHJing HeCorresponding
Peking University, Peking University People's Hospital
- XZXia Zhang
Peking University, Peking University People's Hospital
- YWYunbo Wei
Shandong Academy of Environmental Science, Shandong Academy of Sciences
- XSXiaolin Sun
Peking University, Peking University People's Hospital
- YCYaping Chen
Discovery Institute, Australian Regenerative Medicine Institute, Monash University
Topics & keywords
Topics
Keywords
- Immunology
- Lupus erythematosus
- T cell
- Medicine
- Systemic lupus erythematosus
- Interleukin 15
- Autoimmune disease
- Effector
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.